Skip to main content
Clinical Trials

Phase I study of TTI-101, an oral inhibitor of signal transducer and activator of transcription (STAT) 3, in patients with advanced cancers. CTMS#: 21-0019

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Sukeshi Patel Arora MD

For more information about this study
View Details

About This Study